STCube Inc
KOSDAQ:052020
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
STCube Inc
Net Income (Common)
STCube Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
STCube Inc
KOSDAQ:052020
|
Net Income (Common)
-₩21.8B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-15%
|
|
|
M
|
Makus Inc
KOSDAQ:093520
|
Net Income (Common)
₩23.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
24%
|
CAGR 10-Years
17%
|
|
|
S
|
SAMT Co Ltd
KOSDAQ:031330
|
Net Income (Common)
₩75.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
|
D
|
Dmoa Co Ltd
KOSDAQ:016670
|
Net Income (Common)
₩3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-6%
|
|
|
M
|
Medifron DBT Co Ltd
KOSDAQ:065650
|
Net Income (Common)
-₩54.5B
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-22%
|
|
|
U
|
Unitron Tech Co Ltd
KOSDAQ:142210
|
Net Income (Common)
₩13.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
24%
|
CAGR 10-Years
7%
|
|
STCube Inc
Glance View
STCube, Inc. engages in the development and distribution of information technology (IT) services. The company is headquartered in Seoul, Seoul. The company went IPO on 2001-07-05. Along with subsidiaries, the Company operates its business through two segments. The Information Technology (IT) segment is engaged in the distribution of closed-circuit television (CCTV) lenses and related components. The Biotechnology (BT) segment is engaged in the development and licensing of immunomodulatory anticancer drug therapeutic candidates.
See Also
What is STCube Inc's Net Income (Common)?
Net Income (Common)
-21.8B
KRW
Based on the financial report for Dec 31, 2025, STCube Inc's Net Income (Common) amounts to -21.8B KRW.
What is STCube Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-15%
Over the last year, the Net Income (Common) growth was -2%. The average annual Net Income (Common) growth rates for STCube Inc have been -5% over the past three years , -6% over the past five years , and -15% over the past ten years .
